In this study, we describe a method to reliably characterize intrahepatic leukocyte populations using flow cytometry and next-generation RNA sequencing on fresh human liver biopsies. Over the last decades, immune responses of viral hepatitis patients, and of other liver diseases, have been incompletely characterized. Most studies include peripheral blood samples only, foregoing the possibility to investigate the site of inflammation directly. Here, we show that with an optimized protocol that combines cell sorting and RNA sequencing, we can perform a side by side comparison of both intrahepatic and peripheral immune cells. Using core liver biopsies from chronic hepatitis B virus patients, we show that the expression levels of IFN-stimulated genes and leukocyte-specific genes are markedly different in the liver compartment as compared to the peripheral blood. These observations emphasize the need to sample the liver directly. The variation of gene expression profiles in these chronic hepatitis B patients was considerable, despite the uniform treatment with nucleotide analogs and absence of liver inflammation in these patients.
INTRODUCTION
Our knowledge on immune processes in diseased tissues is still incomplete. The main reason for this is that sampling of many diseased organs is not routinely performed for research purposes, and because blood is the most accessible compartment, the more invasive procedure to obtain tissue is less frequently conducted. This is very clear in case of infections of the liver with hepatitis B virus (HBV) or hepatitis C virus: most studies have examined peripheral blood. Importantly, the few studies that examined the liver demonstrated that the phenotype and function of intrahepatic immune cells differ considerably to that of their peripheral counterparts. [1] [2] [3] [4] [5] In recent years, an increasAbbreviations: FSC, forward scatter; HBV, hepatitis B virus; ISG, IFN-stimulated genes; RIN, RNA integrity number; SSC, sideward scatter ing number of viral hepatitis researchers are describing efforts to fill this gap of knowledge, and are in agreement that a better understanding of liver immunology is crucial for the development of new curative antiviral treatment strategies for chronic hepatitis B. 1, [5] [6] [7] Unfortunately, progress in the field of liver immunology is hampered by practical and technical difficulties. 6 Core liver biopsies are rarely collected for research purposes only, because the associated complication rate is only accepted if the biopsy assists clinical decision making. 8 Also, with the expanding use of noninvasive tests of liver disease, such as fibroscan, 9,10 rest material from liver biopsies is less frequently available. Finally, not all clinical units have a research laboratory able to receive and process liver tissue within hours, which is essential because liver cells are prone to die from apoptosis. 11, 12 Because the number of liver biopsies available is limited, it is essential to make optimal use of all material for research purposes. In the current study, we Table 1 ). A number of groups have reported on the evaluation of liver material collected by fine needle aspiration using a 22-25 Gauge needle for flow cytometry or bulk gene expression profiling. 13, 14 In this study, we aimed to combine these approaches and purify T cell and NK cells from liver biopsies, followed by next-generation sequencing of the RNA isolated from these cells, to increase the information gained from biopsies during future immunological studies.
MATERIALS AND METHODS

Collection of liver biopsies and blood samples
We collected core liver biopsies (18 Gauge) of 6 patients chronically infected with HBV and treated with nucleotide analog therapy. Biopsies were collected in 10 ml PBS + 1% FCS in a 15 ml tube, and kept on ice. The liver biopsy tissue was homogenized by carefully mashing the biopsy using the plunger of a 1 ml syringe in a 48 well flat bottom plate.
PBS + 1% FCS was added until a 200 l cell suspension was formed.
Erythrocyte lysis was not performed and only fresh material was used (no cryopreservation). All biopsies were taken between 9-11 AM and processed for FACS analysis and sorting within the hour. Rapid processing and analysis was crucial to minimize cell death. Patients were monitored for at least 2 h following biopsy collection and no complications related to the liver biopsies were recorded. Heparinized blood was collected from all patients immediately prior to the biopsy procedure. PBMC were isolated by ficoll separation (Ficoll-Paque TM plus, GE Healthcare Life Sciences, Amersham, United Kingdom), counted and 10 6 cells stained using the same antibody panel as the liver biopsies.
FACS sorting procedure
Intrahepatic and peripheral leukocytes were sorted using the FACS Aria II (BD, Franklin Lakes, New Jersey, United States) equipped 
RNA isolation
RNA was isolated using Arcturus R PicoPure R RNA Isolation Kit according to the manufacturer instructions: Briefly, sorted cells were centrifuged (3000 × g, 9 min), the supernatant was discarded, and the pellet incubated for 30 min with extraction buffer. Ethanol (70%) was pipetted onto the supernatant and the cell extract and ethanol mixture was then pipetted onto the prepared purification column and centrifuged twice (2 min at 100 × g, 30 s at 16,000 × g). DNA was removed using by DNAse treatment. RNA integrity was measured using Eukaryote Total RNA Pico assay (Agilent Technologies Inc, Santa Clara, California, United States). Technical information on the RNA sequencing of purified leukocyte populations, the alignment of short reads to the genome and, the analysis of expression of genes and pathways can be found in the Extended Methods on page in the Supplementary Information.
Clinical trial
This study was part of the international trial investigating the safety, tolerability, and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B on nucleotide analog therapy (Clinical Trial
Number: GS-US-283-1059; NCT 02166047). 15 The liver biopsies (18 Gauge) used for the current study were performed at baseline and 24 h after the last eighth dose of vesatolimod. Vesatolimod (GS-9620) is an oral agonist of TLR7. It is currently under investigation for the treatment of both HBeAg-positive and negative chronic HBV.
Our center was the only site to perform liver immune cell isolation (in tandem with PBMC isolation), using an 18 Gauge needle, before and after vesatolimod treatment, and on continuous nucleotide analog therapy. Six noncirrhotic virally suppressed chronic hepatitis B patients on nucleotide analog therapy (age: 29-63 years; 4 males and 2 females) were treated once a week for 7 weeks with 1 mg GS-9620 (n = 3), 2 mg GS-9620 (n = 1), 4 mg GS-9620 (n = 1), or placebo (n = 1).
Blood was collected from the patients prior (week 0) and at 4, 8, 12, 24, and 48 weeks after start of GS-9620 treatment.
Ethical statement
The study was performed in concordance with the Declaration of Helsinki as adopted by the 64th WMA General Assembly, Fortaleza, Brazil, October 2013. The institutional ethical review board of the Erasmus Medical Center approved the protocols, and written informed consent was obtained from all individuals.
RESULTS AND DISCUSSION
As expected, the frequency of NK cells was higher in the liver as compared to the blood (Fig. 1A and B Table 3 ) and NK cell genes (Fig. 2C , Supplementary Table 4 ). It should be noted here that for a relevant assessment of clinical parameters of the patients included, a larger cohort of patients would be necessary. As previously described at the protein level in both cellular compartments, the immune profiles in blood and liver of chronic hepatitis B patients exhibit considerable variation 2, 16 : only small gene clusters (<20 genes) were modulated in the same direction in 2 individual patients (Fig. 2) . We observed less variation in the blood compared to the liver, which emphasizes the need for sampling of the liver, preferably using multiple measurements. In sequential biopsies from a single individual, the frequency of liver-resident lymphocyte populations, including T cells and NK cells, did not vary >2% between biopsies, confirming the reproducibility of the protocol used in our study. All RNA samples derived from T cells and NK cells had good RNA integrity scores, with RIN (RNA integrity number) values of 7 or higher ( Fig. 1D and E ). In the current study, a similar pattern of ISG induction could be observed in T cells and NK cells in liver for each patient, suggesting that these intrahepatic lymphocyte populations are exposed to the same signals (such as type I IFNs), and possibly regulate the transcription of ISG in a similar way. The expression of T cell genes in CD3 + cells in the liver (Fig. 2C) as TNFSF14 (liver NK cells). These genes were among the most liverenriched genes in these HBV patients, which may be related to earlier reports of their role in initiation of fibrogenesis. 19 Finally, using pathway analysis, we aimed to identify the degree of pathway activation in our samples, and compare the blood and liver compartment ( Table 2 contributed to critical revision of the manuscript.
